尤根醇酸对缺血性中风的神经保护作用
Liqiu Chen1,2, Ran Zhang1,2, Jing Xiao1,2
1Department of Neurology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, People's Republic of China.
Journal of inflammation research
|January 13, 2025
概括
尤根醇 (EA) 通过抑制NF-κB通路来减少中风后的神经炎症. 这种化合物可以缓解大脑损伤,并改善小鼠的神经功能,显示出对缺血性中风治疗的希望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 缺血性中风会引发显著的神经炎症.
- 微质细胞在中风后的炎症反应中起着关键作用.
- 针对神经炎症对于中风恢复至关重要.
研究的目的:
- 为了研究尤金醇酸盐 (EA) 的神经保护作用.
- 探索EA对中风后神经炎症及其潜在机制的影响.
- 评估EA作为缺血性中风的潜在治疗剂.
主要方法:
- 在体外研究中使用了用EA,脂多糖 (LPS) 或氧气葡萄糖剥夺 (OGD) 治疗的原发性微质.
- 在体内研究中使用了与EA治疗的中脑动脉封闭 (MCAO) 鼠标模型.
- 测试包括qPCR,ELISA,西部斑点,免疫光,神经行为测试和TTC染色.
主要成果:
- 在微质中,EA显著降低了促炎性细胞因子.
- EA抑制了LPS诱导的NF-κB信号通路的激活.
- 在MCAO小鼠中,EA治疗减轻了脑损伤,改善了神经运动功能,并保持了白质完整性.
结论:
- 尤根醇酸表明神经保护作用对缺血性中风.
- EA的机制涉及抑制微质NF-κB信号传递.
- 作为治疗缺血性中风治疗的候选药物,EA显示出潜在的潜力.
相关概念视频
The Blood-brain Barrier
47.3K
Overview
47.3K
Neurochemical Transmission: Sites of Drug Action
3.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure Drugs: β-Blockers
2.7K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
Neural Regulation of Blood Pressure
8.9K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
8.9K


